首页> Journal of the Pediatric Infectious Diseases Society> Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.

Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ron,Dagan

第一单位： The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences at the Ben-Gurion University of the Negev, Beer-Sheva, Israel.

作者： Ron,Dagan ^[1] ; Laura L,Hammitt ^[2] ; Beatriz,Seoane Nuñez ^[3] ; Manuel,Baca Cots ^[4] ; Miroslava,Bosheva ^[5] ; Shabir A,Madhi ^[6] ; William J,Muller ^[7] ; Heather J,Zar ^[8] ; Yue,Chang ^[9] ; Alexander,Currie ^[10] ; Amy,Grenham ^[9] ; Manish,Shroff ^[11] ; Therese,Takas ^[9] ; Vaishali S,Mankad ^[12] ; Amanda,Leach ^[9] ; Tonya,Villafana ^[9]

作者单位： The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences at the Ben-Gurion University of the Negev, Beer-Sheva, Israel. ^[1] Department of International Health, Johns Hopkins University, Baltimore, Maryland, USA. ^[2] Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Madrid, Spain. ^[3] Paediatric Service, Quirónsalud Málaga Hospital, Málaga, Spain. ^[4] Paediatrics, University Multiprofile, Hospital for Active Treatment, St. George Medical University, Plovdiv, Bulgaria. ^[5] South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit and African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. ^[6] Infectious Diseases, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.;Stanley Manne Children's Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. ^[7] Department of Paediatrics and Child Health, Red Cross Children's Hospital, and the Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa. ^[8] Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA. ^[9] Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. ^[10] Patient Safety, Chief Medical Office, R&D, AstraZeneca, Waltham, Massachusetts, USA. ^[11] Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Durham, North Carolina, USA. ^[12]

关键词 immunization monoclonal antibody nirsevimab respiratory syncytial virus

主题词儿童(Child);人类(Humans);婴儿(Infant);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);呼吸道合胞体病毒, 人(Respiratory Syncytial Virus, Human);呼吸道感染(Respiratory Tract Infections);季节(Seasons)

DOI 10.1093/jpids/piad113

PMID 38219024

发布时间 2024-03-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交